(NASDAQ: SNY) Sanofi's forecast annual revenue growth rate of 3.65% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.81%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.86%.
Sanofi's revenue in 2025 is $50,740,000,000.On average, 5 Wall Street analysts forecast SNY's revenue for 2025 to be $62,602,494,203,913, with the lowest SNY revenue forecast at $56,081,587,789,314, and the highest SNY revenue forecast at $67,060,372,593,248. On average, 5 Wall Street analysts forecast SNY's revenue for 2026 to be $67,625,589,695,950, with the lowest SNY revenue forecast at $60,922,012,999,686, and the highest SNY revenue forecast at $73,317,756,240,810.
In 2027, SNY is forecast to generate $71,046,057,815,791 in revenue, with the lowest revenue forecast at $64,063,247,632,086 and the highest revenue forecast at $77,018,503,713,704.